Basics of Multivariate Analysis in Neuroimaging Data
July 24th, 2010
The current article describes the basics of multivariate analysis and contrasts it to the more commonly used voxel-wise univariate analysis. Both types of analysis are applied to a clinical-neuroscience data set. Supplementary split-half simulations show better replication of the multivariate results in independent data sets.
This video demonstrates and compares multivariate and univa analysis techniques for neuroimaging data with applications to Alzheimer's diagnosis. First brain activity from 20 early Alzheimer's patients in 20 age matched healthy controls is contrasted for the uni variate analysis. SPM is used to identify the brain region that shows the largest relative deficit in FDG PET signal in the Alzheimer's patients relative to control subjects.
For the multi-variate analysis, principal components analysis with linear discriminant analysis is used to derive the marker results indicate that the multi-variate marker provides better diagnostic performance than the uni variate marker and gives superior generalization to independent data. Hello, I'm Christian Halbeck from the TA Institute in the Department of Neurology at Columbia University Medical Center. Today we will show you an example of multivariate data analysis of neuro imaging data.
We use this procedure in our lab to study the optimal way of detecting early Alzheimer's disease from neuro imaging data. So let's get started. Let's begin with a conceptual overview of multivariate analysis of neuroimaging data.
Multivariate approaches evaluate the correlation of activity across brain regions rather than proceeding on a voxel by voxel basis as is done with univa analysis. For example, we can picture a simple hypothetical dataset for 50 human participants where only three regions denoted as voxels in the brain were measured. The general aim of multi-variate analysis is to identify the major sources of variance in the data and then to describe the main effects of interests in the data.
In terms of these sources of variants, uni variate analysis does not pay attention to the correlation between voxels. Both panels seen here would be treated in an identical manner by Univar analysis whether there is correlation between the voxels or not. In this video, the analysis procedure for both univar and multivariate analysis will be demonstrated on a clinical dataset containing FTG PET resting scans for 95 early Alzheimer's patients or AD and 102 H matched controls of all the brain images, 20 were randomly picked of both patients in controls to be the derivation sample.
The remaining 75 and 82 scans respectively constitute the replication sample. Now let's see how to apply both univar and multivariate analyses to this dataset. Beginning with the univa approach, obtain the Univar Alzheimer's disease marker by using SPM software To contrast the 20 ad scans with the 20 control scans in the derivation sample, select the brain location that shows the largest decrease in pet signal in the AD patients as compared to controls.
Using a T-test to test the diagnostic efficacy of this region, check the data in the replication sample for this same brain region, and plot its pet signal as a function of disease status. Next, obtain the multivariate marker. A custom MATLAB toolbox available online is used for the multivariate analysis using the custom MATLAB toolbox.
Perform principle components analysis or PCA on the combined 40 scans in the derivation sample. Then construct a Covance pattern from the first six principle components whose subject score shows a maximal mean difference between 80 patients and healthy controls. Once the diagnostic Covance pattern is obtained from the derivation sample, apply it to the replication sample, plot the resulting subject scores as a function of disease status and compare the performance in the two samples.
To provide a more general comparison of univa and multivariate approaches, perform a split sample simulation and repeat the prior steps 1000 times on resampled data, each time forming a 20 to 20 derivation sample and a 75 to 82 replication of 80 patients and healthy controls afresh. Split sample simulations are common in methodological research since they provide an easy test of the markers derived in the derivation sample by recording their prediction errors in the replication sample, compute univariate and multivariate disease markers from the derivation sample and set the decision threshold such that at most one healthy control is misclassified as ad, which corresponds to a specificity of 95%Finally, apply the disease markers with their specific decision thresholds to the replication samples and record the classification error rates in the replication sample for all resampling iterations. Now we'll take a look at the results of the univa and multivariate analyses and the split sample simulations emulations.
For the univ area analysis. The area of the largest ad related FDG deficit was found in the Precuneus Broadman area 31. The area under the rock curve achieved was 0.90.
The generalization of this contrast to the replication sample was quite good with an area under the rock curve of 0.84 for the multivariate analysis areas with positive loadings hinting at a relative preservation of signal in the face of disease were found in the cerebellum while associated signal loss was found in the parot temporal and frontal areas and the posterior cingulate gyrus, the areas under rock curves in both derivation and replication samples were slightly better than the univariate marker at 0.96 and 0.88 respectively. From the total classification error rates recorded in the 1000 split sample simulations, we can appreciate that the multivariate marker gives better replication of diagnostic performance than the univariate marker. We've just shown you how to apply multivariate analysis to the Alzheimer's diagnostic problem in Ft.G PET scans.
All data is publicly available from the website of the Alzheimer's Disease Neuroimaging Initiative. When performing this procedure on real data, it is important to remember that the usual steps of quality control have been applied prior. No analysis can perform magic on poor data.
So that's it. Thank you for watching and good luck with your analysis.
Overview
This article compares multivariate analysis techniques to univariate analysis in the context of neuroimaging data for Alzheimer's diagnosis. It highlights the advantages of multivariate methods in providing better diagnostic performance and generalization to independent datasets.
Key Study Components
Area of Science
- Neuroscience
- Neuroimaging
- Clinical Research
Background
- Multivariate analysis evaluates correlations across brain regions.
- Univariate analysis examines data on a voxel-by-voxel basis.
- Both methods are applied to clinical datasets for Alzheimer's research.
- Understanding these methods is crucial for improving diagnostic accuracy.
Purpose of Study
- To demonstrate the application of multivariate analysis in neuroimaging.
- To compare the efficacy of multivariate versus univariate analysis in diagnosing Alzheimer's disease.
- To provide insights into the replication of results across independent datasets.
Methods Used
- Analysis of FDG PET scans from early Alzheimer's patients and healthy controls.
- Use of SPM for univariate analysis to identify brain regions with deficits.
- Application of principal components analysis and linear discriminant analysis for multivariate analysis.
- Split-half simulations to evaluate the robustness of diagnostic markers.
Main Results
- The multivariate marker showed better diagnostic performance than the univariate marker.
- Areas under the ROC curve were higher for multivariate analysis in both derivation and replication samples.
- Split sample simulations confirmed the superior replication of multivariate results.
- Key brain regions associated with Alzheimer's were identified through both analysis methods.
Conclusions
- Multivariate analysis provides enhanced diagnostic capabilities for Alzheimer's disease.
- Robustness of results is crucial for clinical applications.
- Further research is needed to refine these analytical techniques.
Frequently Asked Questions
Executive Industry Relevance
Multivariate analysis of neuroimaging data offers enhanced statistical power and reproducibility for target validation in neurodegenerative disease research. By evaluating interregional correlations rather than voxel-wise signals, this approach provides a more biologically meaningful signature of neural network alterations. Such mechanistic de-risking supports predictive confidence in early discovery stages, particularly for Alzheimer's and related disorders where network-level pathophysiology is central to disease mechanism.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by identifying correlated brain region activity patterns that reflect disease-related network dysfunction.
- Operational Value: Enables biological de-risking through multivariate markers that capture distributed pathophysiology beyond single-region effects.
- Predictive Value: Supports portfolio triage by providing diagnostic markers with superior generalization to independent datasets, reducing failure risk in translational progression.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream workflows by establishing reproducible neuroimaging signatures linked to disease status.
- Operational Value: Addresses assay standardization and quantitative output requirements through principal component-derived patterns with defined decision thresholds.
- Scalability: Highlights platform reuse potential via split-sample validation protocols that assess marker robustness across resampled cohorts.
Translational & Preclinical Research
- Scientific Value: Discusses disease relevance through application to ADNI data, demonstrating alignment with Alzheimer's pathophysiology.
- Operational Value: Describes continuity from discovery through preclinical validation by showing how derivation-sample markers generalize to replication samples.
- Risk-Adjusted Advancement: Addresses risk-adjusted advancement decisions by demonstrating superior replication performance in 1000 split-sample simulations.
Pipeline & Workflow Integration
Positions multivariate analysis within the discovery continuum from hypothesis testing to lead identification, supporting biological de-risking and predictive modeling in neurodegenerative disease programs.
- Discovery Biology: Explains how the method supports hypothesis testing by identifying major sources of variance and main effects of interest in neuroimaging data.
- Screening: Describes assay readiness through quantitative subject scores derived from principal components and linear discriminant analysis.
- Analytics: Highlights measurements such as area under the ROC curve and classification error rates that enable cross-condition comparison and threshold setting.
- Translational Research: Connects the method to preclinical continuity by demonstrating generalization of diagnostic markers from derivation to replication samples.
- Enterprise Reuse: Frames the method as a reusable capability through split-sample simulation frameworks that validate marker performance across independent datasets.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in neuroimaging-based disease modeling.
- Operational Value: Standardization, reproducibility, and scalability of multivariate markers derived via PCA and LDA pipelines.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk through improved marker generalization.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on replication performance in simulated independent cohorts.
Implementation Considerations
- Required scientific expertise in multivariate statistics, neuroimaging, and computational toolkits such as MATLAB.
- Instrumentation and analytical infrastructure needs including access to SPM for univariate contrast and custom toolboxes for PCA-LDA workflows.
- Cross-team standardization requirements for defining derivation/replication splits, threshold settings (e.g., 95% specificity), and simulation protocols.
- Adaptation considerations across model systems, particularly regarding preprocessing steps and regional feature selection for PCA.
- Practical limitations supported by source material: high barrier of entry due to methodological complexity and need for large, well-characterized datasets to avoid overfitting.
